Welcome to LookChem.com Sign In|Join Free
  • or
1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboxamide is a chemical compound characterized by the molecular formula C17H12FN3O. It is a pyrazolopyridine derivative featuring a fluorobenzyl group attached to the nitrogen atom of the pyrazolopyridine ring. 1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboxaMide possesses potential pharmaceutical properties and is of interest in medicinal chemistry for the development of new drugs. Due to its chemical nature, it is crucial to handle 1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboxaMide with care, as it may present certain hazards associated with its use and manipulation.

256376-62-2

Post Buying Request

256376-62-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

256376-62-2 Usage

Uses

Used in Pharmaceutical Industry:
1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboxamide is utilized as a pharmaceutical intermediate for the synthesis of novel drugs. Its unique structure and potential biological activity make it a valuable candidate for the development of therapeutic agents targeting various diseases and conditions.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboxamide serves as a key compound for research and development. It is employed in the design and synthesis of new chemical entities with potential therapeutic applications, contributing to the advancement of drug discovery and innovation.

Check Digit Verification of cas no

The CAS Registry Mumber 256376-62-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,5,6,3,7 and 6 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 256376-62:
(8*2)+(7*5)+(6*6)+(5*3)+(4*7)+(3*6)+(2*6)+(1*2)=162
162 % 10 = 2
So 256376-62-2 is a valid CAS Registry Number.

256376-62-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-[(2-fluorophenyl)methyl]pyrazolo[3,4-b]pyridine-3-carboxamide

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:256376-62-2 SDS

256376-62-2Relevant academic research and scientific papers

PROCESS FOR THE PREPARATION OF METHYL 4,6-DIAMINO-2-[L-(2-FHIOROBENZVR)-LH-PYRAZOLO I3,4-BLPVRIDIN-3-VN-5-PYRIMIDINYL(METHVL)CARBAMATE AND ITS POLYMORPHS THEREOF

-

, (2017/03/08)

The present invention relates to process for the preparation of methyl 4,6-diamino-2-[1-(2-fluorobenzyl)-lH-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl(methyl)carbamate and its polymorphs thereof compound of formula-1, represented by the following structur

Novel Combination Containing a Stimulator of Soluble Guanylate Cyclase and a Lipid-Lowering Substance

-

Page/Page column 9, (2010/11/28)

A combination product which comprises as pharmaceutically active ingredients at least one active ingredient component A and at least one active ingredient component B, where active ingredient component A is a direct soluble guanylate cyclase stimulator of

Novel sulfonamide-substituted pyrazolopyridine derivatives

-

, (2008/06/13)

The invention relates to novel pyrazolopyridine derivatives of formula (I) wherein R1 represents H, Cl or NH2, and R2 and R3 form; together with the heteroatoms to which they are bonded, a five to six-membered heterocycle which can be saturated or partially unsaturated, can optionally contain at least one other heteroatom from the group N, O, S and can be optionally substituted. The invention also relates to salts, isomers and hydrates of said derivatives, in the form of stimulators of soluble guanylate cyclase and as agents for treating cardiovascular diseases, hypertonia, thrombo-embolic diseases and ischaemia, sexual dysfunction, inflammations, and diseases of the central nervous system.

Novel carbamate-substituted pyrazolopyridine derivatives

-

, (2008/06/13)

The invention relates to novel pyrazolopyridine derivatives of the formula (I), wherein R1 represents hydrogen or a di-C1-6-alkylaminocarbonyl group, R2 represents a rest of the formula —O—CO—NR3R4, wherein R3 and R4 are the same or different and represen

NOVEL 2,5-DISUBSTITUTED PYRIMIDINE DERIVATIVES

-

Page/Page column 29-30, (2010/02/06)

The invention relates to novel 2,5-disubstituted pyrimidine derivatives, which stimulate the soluble guanylate cyclase, method for production and use thereof for the production of medicaments, in particular medicaments for the treatment of central nervous system diseases.

4-AMINO-SUBSTITUTED PYRIMIDINE DERIVATIVES

-

Page/Page column 21-22, (2010/02/06)

The invention relates to novel 4-amino-substituted pyrimidine derivatives, which stimulate soluble guanylate cyclase, method for production and use thereof for the production of medicaments, in particular medicaments for the treatment of diseases of the c

PYRIDINE-SUBSTITUTED PYRAZOLOPYRIDINE DERIVATIVE

-

Page/Page column 11-12, (2010/02/06)

The invention relates to a substituted pyrazole derivative and the use thereof as a medicament, particularly as a medicament for treating cardiovascular diseases.

Substituted pyrazole derivatives condensed with six-membered heterocyclic rings

-

Page column 42, (2010/02/07)

The present invention relates to novel substituted pyrazole derivatives of the general formula (I) in which R1, R2, R3and A are each as defined, and to processes for their preparation and to their use as medicaments, in pa

Substituted pyrazole derivatives

-

Page column 32, (2010/02/09)

The present invention relates to novel substituted pyrazole derivatives of the general formula (I) in which the substituents R1, R2, R3, A, X and Y are each as defined, and to processes for their preparation and to their use as medicaments, in particular as medicaments for the treatment of cardiovascular disorders.

Pyridine-substituted pyrazolopyridine derivatives

-

, (2008/06/13)

The present invention relates to new pyrazolopyridine derivatives of the formula (I) in which R1 represents 4-pyridinyl or 3-pyridinyl; R2 represents H, NH2 or halogen; and salts, isomers and hydrates thereof as stimulator

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 256376-62-2